INS and metabolic disease: MSCs have an immunosuppressive effect and secrete a variety of cytokines, improve the microenvironment of diabetic patients, target insulin-resistant tissue, ameliorate the metabolic disorder of islet damage, and protect and regenerate islet β-cells, thereby reducing blood sugar levels.